AI in Drug Discovery

Isomorphic Labs, a DeepMind spinoff, aims to revolutionize drug discovery by cutting time from 5 to 2 years using AI. Partnerships with Eli Lilly and Novartis show a shift towards profitability for DeepMind's ventures.